Gastric preparation for magnetically controlled capsule endoscopy: A prospective, randomized single-blinded controlled trial

Shuguang Zhu(Second Military Medical University), Zhuan Liao(Second Military Medical University), Han Du(University of California, Los Angeles), Xiaoju Su(Second Military Medical University), Anjing Zhao(Second Military Medical University), Mark McAlindon(Sheffield Teaching Hospitals NHS Foundation Trust), Hey‐Long Ching(Sheffield Teaching Hospitals NHS Foundation Trust), Yang‐Yang Qian(Second Military Medical University), Zhao‐Shen Li(Second Military Medical University), Qianqian Zhu(Second Military Medical University), Xin‐Ying Tang(Second Military Medical University), Wei Zhou(Broad Institute), Wei An(Chengdu University of Traditional Chinese Medicine)
Digestive and Liver Disease
October 12, 2017
10.1016/j.dld.2017.09.129
Cited by 52

Related Papers

Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial
|The Lancet Oncology|2015|1.6k
Small-bowel capsule endoscopy and device-assisted enteroscopy for diagnosis and treatment of small-bowel disorders: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline
|Endoscopy|2015|885
Association of adult coeliac disease with irritable bowel syndrome: a case-control study in patients fulfilling ROME II criteria referred to secondary care
|The Lancet|2001|392
In vitro and in vivo evidence that quercetin protects against diabetes and its complications: A systematic review of the literature
|Biomedicine & Pharmacotherapy|2018|291
Targeting p21-activated kinase 1 (PAK1) to induce apoptosis of tumor cells
|Proceedings of the National Academy of Sciences|2011|256